WRITING THE FUTURE a s i a pac i f i c april 28, 2021 | 08:30–13:00 sgt 08:30 Writing the Future with Twist Bioscience Emily Leproust, Twist Bioscience 09:00 Increasing the Precision of Precision Medicine for Children with High-risk Cancer Mark Cowley, Children’s Cancer Institute 09:30 Capturing History in DNA at the National Film & Sound Archive of Australia Ross Garrett, National Film and Sound Archive of Australia 09:55 Networking Join our speakers and the Twist team for conversation in our Networking Hall Be sure to enable your microphone and camera Once in the room, use your arrow keys to move around and “bump” into others to join in on the conversation! BREAKOUT SESSIONS Advancing Human Health through Genomics Advancing Science with Synthetic Biology 10:15 The Next Generation of Targeted Methylation Sequencing Bryan Höglund, Twist Bioscience Tools for the Good Fight Rebecca Nugent, Twist Bioscience 10:30 Hit Two Birds with One Stone: Hybrid-capture Ki Wook Kim, University of New South Wales Using Novel Tools of Synthetic Biology to Understand Complex Diseases via Functional Genomics Shea Ping Yip, The Hong Kong Polytechnic University 10:55 Saving Lives by Detecting Cancer Early Ken Chahine, Helio Health Predicting the Efficiencies and Outcomes of Genome Editing and Time-recording Using Cas9 Hyongbum Henry Kim, Yonsei University College of Medicine 11:20 Networking Join our speakers and the Twist team for conversation in our Networking Hall Be sure to enable your microphone and camera Once in the room, use your arrow keys to move around and “bump” into others to join in on the conversation! BREAKOUT SESSIONS Advancing Human Health through Genomics Advancing Science with Synthetic Biology 11:40 Comprehensive Omics Analysis to Explore Applications in Clinical Oncology Kui Wu, BGI-Research Travelling Back in Time with Synthetic Biology: New Insights into Fundamental Biophysical Processes Colin J Jackson, The Australian National University 12:05 The Evolution of Clinical Genomics at VCGS: Past, Present & Future Sebastian Lunke, Victorian Clinical Genetics Services Identifying and Cloning Neoepitope Specific, CD4+ T Cells from Newly Diagnosed Glioma Patients in a Phase I Vaccination Trial Targeting Mutant IDH1 Edward Green, German Cancer Research Center (DKFZ) 12:30 Targeting Tumor Mutations With Personalized T Cell Therapy Of Cancer Gavin Bendle, Neogene Therapeutics 13:00 Wrap up & Close